Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 105 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Post Myocardial Infarction Clear all

Conditions: Ventricular Tachycardia, Ischemic Heart Disease, Sustained VT
Interventions: RFA Ablation, PFA Ablation; Device
Lead sponsor: Pasquale Santangeli; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Myocardial Infarction, Myocardial Ischemia
Interventions: thymosin beta 4, Placebo; Drug · Other
Lead sponsor: RegeneRx Biopharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 79 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Cardiovascular Events, MACE
Interventions: Tezepelumab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 12 Years to 130 Years
Enrollment: 16,640 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Interventions: CD-NP; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Acute ST Segment Elevation Myocardial Infarction, Acute Coronary Syndrome
Interventions: Ticagrelor, Clopidogrel; Drug
Lead sponsor: Medical Center of South Arkansas; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: El Dorado, Arkansas

Conditions: Coronary Artery Disease, Death, Myocardial Infarction
Interventions: Not listed
Lead sponsor: VA Boston Healthcare System; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: West Roxbury, Massachusetts

Conditions: Stroke, Acute, Stroke, Stroke, Cardiovascular, Stroke (CVA) or TIA, Stroke/Brain Attack
Interventions: Group Lifestyle Balance for People Post Stroke (GLB-CVA); Behavioral
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 85 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Stable Coronary Artery Disease (CAD), Myocardial Infarction
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years and older
Enrollment: 9,284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 34
States / cities: Huntsville, Alabama • Los Angeles, California • Santa Ana, California + 31 more

Conditions: ST Segment Elevation Myocardial Infarction
Interventions: NBS10, placebo; Biological · Other
Lead sponsor: Lisata Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 58
States / cities: Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 50 more

Conditions: Myocardial Infarction, Comorbidity
Interventions: VA MI Plus Interactive; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 847 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 40
States / cities: Birmingham, Alabama • Phoenix, Arizona • Fayetteville, Arkansas + 36 more

Conditions: ST Segment Elevation Acute Myocardial Infarction
Interventions: Anakinra, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Anterior Wall Acute Myocardial Infarction
Interventions: SSO2 Therapy; Device
Lead sponsor: TherOx; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 15
States / cities: Huntsville, Alabama • La Jolla, California • Danbury, Connecticut + 11 more

Conditions: Acute Myocardial Infarction, Heart Failure
Interventions: Anakinra, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Acute ST Elevation Myocardial Infarction
Interventions: Epoetin alfa; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 21 Years and older
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 16
States / cities: Washington D.C., District of Columbia • Miami, Florida • Atlanta, Georgia + 11 more

Conditions: Cardiovascular Disease, Myocardial Infarction, Stroke, Coronary Revascularization
Interventions: Evolocumab, Routine Lipid Management; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 6,019 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 81
States / cities: Birmingham, Alabama • Fairhope, Alabama • Huntsville, Alabama + 73 more

Conditions: Acute Myocardial Infarction (AMI)
Interventions: Home-based physical therapy, Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 70 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Hyperoxia, Myocardial Infarction, Myocardial Injury
Interventions: Inspiratory oxygen fraction; Drug
Lead sponsor: University Hospital Bispebjerg and Frederiksberg; Other
Eligibility: 18 Years and older
Enrollment: 7,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Myocardial Infarction, Ventricular Dysfunction, Sudden Death, Ventricular Tachycardia, Ventricular Fibrillation
Interventions: wearable defibrillator; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 57
States / cities: Anchorage, Alaska • Fresno, California • Salinas, California + 47 more

Conditions: Myocardial Infarction (MI)
Interventions: Not listed
Lead sponsor: AstraZeneca; Industry
Eligibility: Up to 130 Years
Enrollment: 7,035 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Bethesda, Maryland • Waltham, Massachusetts

Conditions: Acute Kidney Injury, Renal Insufficiency, Chronic, Heart Failure, Myocardial Infarction, Arrhythmias, Cardiac, Stroke
Interventions: Transcatheter Aortic Valve Replacement; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 3
States / cities: Dallas, Texas

Conditions: Acute Coronary Syndrome
Interventions: Losmapimod 7.5 mg twice daily, Placebo twice daily, Standard therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 35 Years and older
Enrollment: 3,503 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 91
States / cities: Huntsville, Alabama • Cottonwood, Arizona • Tucson, Arizona + 83 more

Conditions: Myocardial Infarction
Interventions: Post-conditioning; Procedure
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Acute Myocardial Infarction (AMI)
Interventions: Clopidogrel, Prasugrel, Ticagrelor; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 377,753 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Myocardial Infarction
Interventions: Follow-up Appointment- early vs standard; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Tezspire Cardiac Events PASS

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis

Long-term Outcomes of Patients After Coronary Bifurcation Stenting

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction

Web-Enhanced Guideline Implementation for Post MI CBOC Patients

Anakinra to Prevent Post-infarction Remodeling

Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)

Anakinra to Prevent Adverse Post-infarction Remodeling (2)

REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction

Intraoperative Hyperoxia and MINS

Vest Prevention of Early Sudden Death Trial and VEST Registry

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Post-conditioning to Reduce Infarct Size

Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction

The Impact of Early Follow-up on Readmission Rates in AMI Patients